Q4 2025 Holdings
Filed 2026-02-17 | 45 holdings | $186.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $18.8M | 85,098 | 10.1% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $17.9M | 443,777 | 9.6% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $16.8M | 718,354 | 9.0% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $13.0M | 366,238 | 7.0% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $8.1M | 525,592 | 4.3% |
| Sionna Therapeutics Inc(SION) | COM | 829401108 | $7.4M | 180,593 | 4.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $7.3M | 288,677 | 3.9% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $6.8M | 37,433 | 3.7% |
| Savara Inc(SVRA) | COM | 805111101 | $6.0M | 995,353 | 3.2% |
| Mind Medicine Mindmed Inc(BRD1EUR) | COM NEW | 60255C885 | $5.7M | 425,202 | 3.0% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $5.4M | 980,768 | 2.9% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $5.1M | 418,080 | 2.7% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $5.0M | 352,896 | 2.7% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $4.9M | 2,253,550 | 2.6% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $4.6M | 9,451 | 2.5% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $4.4M | 54,879 | 2.3% |
| Belite BIO Inc(BLTE) | SPONSORED ADS | 07782B104 | $4.0M | 24,703 | 2.1% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $3.7M | 47,278 | 2.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $3.5M | 196,853 | 1.9% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $3.0M | 83,353 | 1.6% |
| Quince Therapeutics Inc(QNCX) | COM | 22053A107 | $2.9M | 858,711 | 1.5% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $2.8M | 153,313 | 1.5% |
| Capricor Therapeutics Inc(CAPR) | COM NEW | 14070B309 | $2.8M | 96,334 | 1.5% |
| Palvella Therapeutics Inc NE(PVLA) | COM | 697947109 | $2.7M | 25,469 | 1.4% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $2.4M | 88,308 | 1.3% |
| Assembly Biosciences Inc(ASMB) | COM NEW | 045396207 | $2.2M | 65,273 | 1.2% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $2.1M | 255,370 | 1.1% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $1.9M | 360,000 | 1.0% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $1.9M | 148,292 | 1.0% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $1.5M | 58,677 | 0.8% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $1.5M | 38,022 | 0.8% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $1.3M | 43,230 | 0.7% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $1.2M | 513,765 | 0.6% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $1.1M | 26,249 | 0.6% |
| Spruce Biosciences Inc(SPRB) | COM NEW | 85209E208 | $1.1M | 12,137 | 0.6% |
| Aardvark Therapeutics Inc(AARD) | COM | 002942100 | $912.1K | 69,496 | 0.5% |
| Genmab A/S(GMAB) | SPONSORED ADS | 372303206 | $898.2K | 29,162 | 0.5% |
| Palisade BIO Inc(PALI) | COM | 696389402 | $862.7K | 367,103 | 0.5% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $815.0K | 72,060 | 0.4% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $730.0K | 31,738 | 0.4% |
| Palatin Technologies Inc(PTN) | COM NEW | 696077601 | $522.5K | 33,971 | 0.3% |
| Inventiva SA(IVA) | ADS | 46124U107 | $465.0K | 100,000 | 0.2% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $460.6K | 462,963 | 0.2% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $310.0K | 250,000 | 0.2% |
| Entera BIO LTD(ENTX) | SHS | M40527109 | $33.3K | 17,142 | 0.0% |